Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly-Reference-Cited by-同舟云学术

Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly

Published:2021-08-01 Issue:15 Volume:60 Page:2451-2459
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Yasuda Shigemitsu¹,Inoue Ikuo¹,Shimada Akira¹

Affiliation:

1. Department of Endocrinology and Diabetes, Saitama Medical University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/15/60_4981-20/_pdf

Reference37 articles.

1. 1. Bizzarri C, Bottaro G. Endocrine implications of neurofibromatosis 1 in childhood. Horm Res Paediatr 83: 232-241, 2015.

2. 2. National Institutes of Health Consensus Development Conference Statement. Neurofibromatosis. Arch Neurol Chicago 45: 575-578, 1988.

3. 3. Jett K, Friedman JM. Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12: 1-12, 2010.

4. 4. Cimino PJ, Gutmann DH. Neurofibromatosis type 1. Handb Clin Neurol 148: 799-811, 2018.

5. 5. Yoshida Y, Kuramochi A, Oota Y, et al. Clinical guidelines for neurofibromatosis type 1 (Recklinghausen disease) 2018. Nihon Hifukagakkai Zasshi 128: 17-34, 2018 (in Japanese).

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the Genetic Secrets of Acromegaly: Exploring the Role of Genetics in a Rare Disorder;Current Issues in Molecular Biology;2024-08-20

2. Genetic diagnosis in acromegaly and gigantism: From research to clinical practice;Best Practice & Research Clinical Endocrinology & Metabolism;2024-05